Surgeons at NYU Langone’s Heart Valve Center are among the most experienced and sought-out in the country for the treatment of people with heart valve disease.
We are leaders and innovators in the care of people with aortic valve disease, mitral valve disease, and tricuspid valve disease, using transcatheter, robotic, and traditional surgical techniques. Our surgeons were the first in the country to perform several procedures, from a port access mitral valve repair to nonsurgical mitral valve replacement.
We are pioneers in transcatheter approaches for the treatment of heart valve disease that result in quicker, easier recoveries for our patients. During a nonsurgical transcatheter procedure, doctors use a blood vessel in the groin to advance a catheter into your heart. The catheter insertion site in the leg generally needs no more than a Band-Aid, and this short procedure typically allows patients to return home the next day.
To continue the advancement of heart valve technologies and procedures, we are actively involved in research and are currently participating in more than a dozen clinical trials.
Our surgeons have performed more than 3,000 transcatheter aortic valve replacements, among the most in the country. We were the first in the world to perform an advanced type of transcatheter aortic valve implantation (TAVI) or transcatheter aortic valve replacement (TAVR) using the new Medtronic CoreValve™ Evolut™ R Pro System.
“I went in for the TAVR procedure, and I went home the next day. A week later, I had no restrictions on my activity.”
–Thomas, 73; Read All Heart Valve Disease Patient Stories
Our outcomes are among the best in the country. Most patients who have had TAVR recover quickly enough to only require a one-day hospital stay, compared with a nationwide average of three days. Our patients return home twice as quickly as others treated in the region. The survival rate of our patients after TAVR is 99 percent, and our patients have fewer complications than the national average, including a 6-times-lower risk of stroke.
Our cardiac surgeons have performed more than 5,000 mitral valve repair procedures—among the most in the country. We offer a non-surgical percutaneous, or through the skin, mitral valve repair with MitraClip®. During this procedure, a small clip is threaded through a catheter that has been inserted in the femoral vein in the leg. Doctors place the clip on the mitral valve to stop it from leaking.
Our doctors perform more MitraClip® procedures than any other center in the northeast. Nearly all of our patients—97 percent—experience a reduction in mitral regurgitation after the procedure, which leads to a better quality of life. Our risk of complications is four times less than the national average, without any mortality related to the procedure.
We also offer transcatheter mitral valve replacement (TMVR) and were the first to use the LivaNova Caisson TMVR valve for this procedure.